Patients with MDCCAID suffer from congenital muscular dystrophy with hypoglycosylation of dystroglycan (Osborn et al., 2017; Wiessner et al., 2017). The gene discussed is DAG1; the disease is muscular dystrophy, congenital, with cataracts and intellectual disability.